vs
三维系统（DDD）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
三维系统的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$106.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -4.3%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-16.6M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.6%）
3D Systems是一家总部位于美国南卡罗来纳州罗克希尔的企业，核心业务涵盖3D打印机、3D打印材料的研发生产与销售，同时提供3D打印零部件定制及应用工程服务，可产品概念模型、精密功能原型、工裝母模以及直接数字化生产零部件等产品，服务各行各业的数字化制造需求。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DDD vs PBYI — 直观对比
营收规模更大
DDD
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出32.0%
-4.3%
自由现金流更多
PBYI
多$31.0M
$-16.6M
两年增速更快
PBYI
近两年复合增速
1.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $106.3M | $75.5M |
| 净利润 | $-19.5M | — |
| 毛利率 | 30.8% | 69.3% |
| 营业利润率 | -21.3% | 22.7% |
| 净利率 | -18.4% | — |
| 营收同比 | -4.3% | 27.7% |
| 净利润同比 | 41.7% | — |
| 每股收益（稀释后） | $0.04 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DDDPBYI
| Q4 25 | $106.3M | $75.5M | ||
| Q3 25 | $91.2M | $54.5M | ||
| Q2 25 | $94.8M | $52.4M | ||
| Q1 25 | $94.5M | $46.0M | ||
| Q4 24 | $111.0M | $59.1M | ||
| Q3 24 | $112.9M | $80.5M | ||
| Q2 24 | $113.3M | $47.1M | ||
| Q1 24 | $102.9M | $43.8M |
净利润DDDPBYI
| Q4 25 | $-19.5M | — | ||
| Q3 25 | $-18.1M | $8.8M | ||
| Q2 25 | $104.4M | $5.9M | ||
| Q1 25 | $-37.0M | $3.0M | ||
| Q4 24 | $-33.5M | — | ||
| Q3 24 | $-178.6M | $20.3M | ||
| Q2 24 | $-27.3M | $-4.5M | ||
| Q1 24 | $-16.0M | $-4.8M |
毛利率DDDPBYI
| Q4 25 | 30.8% | 69.3% | ||
| Q3 25 | 32.3% | 77.7% | ||
| Q2 25 | 38.1% | 76.5% | ||
| Q1 25 | 34.6% | 77.1% | ||
| Q4 24 | 31.0% | 76.4% | ||
| Q3 24 | 36.9% | 63.9% | ||
| Q2 24 | 41.6% | 77.4% | ||
| Q1 24 | 39.8% | 75.5% |
营业利润率DDDPBYI
| Q4 25 | -21.3% | 22.7% | ||
| Q3 25 | -23.4% | 17.6% | ||
| Q2 25 | -16.2% | 12.7% | ||
| Q1 25 | -38.9% | 8.7% | ||
| Q4 24 | -27.4% | 22.6% | ||
| Q3 24 | -160.0% | 27.4% | ||
| Q2 24 | -23.3% | -4.6% | ||
| Q1 24 | -38.7% | -5.3% |
净利率DDDPBYI
| Q4 25 | -18.4% | — | ||
| Q3 25 | -19.8% | 16.2% | ||
| Q2 25 | 110.1% | 11.2% | ||
| Q1 25 | -39.1% | 6.5% | ||
| Q4 24 | -30.1% | — | ||
| Q3 24 | -158.2% | 25.2% | ||
| Q2 24 | -24.1% | -9.6% | ||
| Q1 24 | -15.5% | -11.0% |
每股收益（稀释后）DDDPBYI
| Q4 25 | $0.04 | $0.26 | ||
| Q3 25 | $-0.14 | $0.17 | ||
| Q2 25 | $0.57 | $0.12 | ||
| Q1 25 | $-0.28 | $0.06 | ||
| Q4 24 | $-0.26 | $0.40 | ||
| Q3 24 | $-1.35 | $0.41 | ||
| Q2 24 | $-0.21 | $-0.09 | ||
| Q1 24 | $-0.12 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $95.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $240.4M | $130.3M |
| 总资产 | $521.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DDDPBYI
| Q4 25 | $95.6M | $97.5M | ||
| Q3 25 | $95.5M | $94.4M | ||
| Q2 25 | $116.4M | $96.0M | ||
| Q1 25 | $135.0M | $93.2M | ||
| Q4 24 | $171.3M | $101.0M | ||
| Q3 24 | $190.0M | $96.7M | ||
| Q2 24 | $192.7M | $96.8M | ||
| Q1 24 | $212.0M | $107.2M |
总债务DDDPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益DDDPBYI
| Q4 25 | $240.4M | $130.3M | ||
| Q3 25 | $221.1M | $115.3M | ||
| Q2 25 | $241.2M | $104.7M | ||
| Q1 25 | $145.6M | $97.1M | ||
| Q4 24 | $176.2M | $92.1M | ||
| Q3 24 | $218.0M | $71.1M | ||
| Q2 24 | $381.7M | $48.5M | ||
| Q1 24 | $408.4M | $51.0M |
总资产DDDPBYI
| Q4 25 | $521.7M | $216.3M | ||
| Q3 25 | $554.5M | $202.9M | ||
| Q2 25 | $587.8M | $194.9M | ||
| Q1 25 | $583.4M | $196.2M | ||
| Q4 24 | $608.8M | $213.3M | ||
| Q3 24 | $658.3M | $220.7M | ||
| Q2 24 | $821.5M | $205.0M | ||
| Q1 24 | $857.2M | $214.1M |
负债/权益比DDDPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-16.6M | $14.4M |
| 自由现金流率自由现金流/营收 | -15.7% | 19.1% |
| 资本支出强度资本支出/营收 | 1.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-97.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流DDDPBYI
| Q4 25 | $-14.7M | $14.4M | ||
| Q3 25 | $-13.5M | $9.7M | ||
| Q2 25 | $-25.8M | $14.1M | ||
| Q1 25 | $-33.8M | $3.6M | ||
| Q4 24 | $-7.8M | $15.6M | ||
| Q3 24 | $-801.0K | $11.0M | ||
| Q2 24 | $-10.8M | $1.0M | ||
| Q1 24 | $-25.5M | $11.2M |
自由现金流DDDPBYI
| Q4 25 | $-16.6M | $14.4M | ||
| Q3 25 | $-15.8M | $9.7M | ||
| Q2 25 | $-28.8M | $14.1M | ||
| Q1 25 | $-36.6M | $3.6M | ||
| Q4 24 | $-13.1M | $15.6M | ||
| Q3 24 | $-4.4M | $11.0M | ||
| Q2 24 | $-14.7M | $1.0M | ||
| Q1 24 | $-28.7M | — |
自由现金流率DDDPBYI
| Q4 25 | -15.7% | 19.1% | ||
| Q3 25 | -17.3% | 17.7% | ||
| Q2 25 | -30.4% | 26.8% | ||
| Q1 25 | -38.7% | 7.7% | ||
| Q4 24 | -11.8% | 26.4% | ||
| Q3 24 | -3.9% | 13.7% | ||
| Q2 24 | -13.0% | 2.1% | ||
| Q1 24 | -27.9% | — |
资本支出强度DDDPBYI
| Q4 25 | 1.8% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 3.1% | 0.0% | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 4.8% | 0.0% | ||
| Q3 24 | 3.2% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% | ||
| Q1 24 | 3.1% | 0.0% |
现金转化率DDDPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | -0.25× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DDD
| Products | $62.6M | 59% |
| Services | $43.7M | 41% |
PBYI
暂无分部数据
